Prophylactic antibiotic use for penetrating trauma in prolonged casualty care: A review of the literature and current guidelines
- PMID: 38689405
- DOI: 10.1097/TA.0000000000004355
Prophylactic antibiotic use for penetrating trauma in prolonged casualty care: A review of the literature and current guidelines
Abstract
Prolonged casualty care (PCC), previously known as prolonged field care, is a system to provide patient care for extended periods of time when evacuation or mission requirements surpass available capabilities. Current guidelines recommend a 7- to 10-day course of ertapenem or moxifloxacin, with vancomycin if methicillin-resistant Staphylococcus aureus is suspected, for all penetrating trauma in PCC. Data from civilian and military trauma have demonstrated benefit for antibiotic prophylaxis in multiple types of penetrating trauma, but the recommended regimens and durations differ from those used in PCC, with the PCC guidelines generally recommending broader coverage. We present a review of the available civilian and military literature on antibiotic prophylaxis in penetrating trauma to discuss whether a strategy of broader coverage is necessary in the PCC setting, with the goal of optimizing patient outcomes and antibiotic stewardship, while remaining cognizant of the challenges of moving medical material to and through combat zones. Empiric extended gram-negative coverage is unlikely to be necessary for thoracic, maxillofacial, extremity, and central nervous system trauma in most medical settings. However, providing the narrowest appropriate antimicrobial coverage is challenging in PCC because of limited resources, most notably, delay to surgical debridement. Antibiotic prophylaxis regimen must be determined on a case-by-case basis based on individual patient factors while still considering antibiotic stewardship. Narrower regimens, which focus on matching up the site of infection to the antibiotic chosen, may be appropriate based on available resources and expertise of treating providers. When resources permit in PCC, the narrower cefazolin-based regimens (with the addition of metronidazole for esophageal or abdominal involvement, or gross contamination of central nervous system trauma) likely provide adequate coverage. Levofloxacin is appropriate for ocular trauma. Ideally, cefazolin and metronidazole should be carried by medics in addition to first-line antibiotics (moxifloxacin and ertapenem, Literature Synthesis and Expert Opinion; Level V).
Copyright © 2024 Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.
References
-
- Remley M, Loos P, Riesberg J, Montgomery H, Drew B, Keenan S, et al. Prolonged Casualty Care Guidelines. In: Clinical Practice Guidelines . Joint Trauma System, 2021 Updated 2023. Available from: https://jts.health.mil/index.cfm/PI_CPGs/cpgs . Accessed December 14, 2023.
-
- Hospenthal DR, Murray CK, Andersen RC, Bell RB, Calhoun JH, Cancio LC, et al. Guidelines for the prevention of infections associated with combat-related injuries: 2011 update: endorsed by the Infectious Diseases Society of America and the surgical infection society. J Trauma . 2011;71(2 Suppl 2):S210–S234.
-
- Freeman JJ, Asfaw SH, Vatsaas CJ, Yorkgitis BK, Haines KL, Burns JB, et al. Antibiotic prophylaxis for tube thoracostomy placement in trauma: a practice management guideline from the Eastern Association for the Surgery of Trauma. Trauma Surg Acute Care . 2022;7:e000886.
-
- Sanabria A, Valdivieso E, Gomez G, Echeverry G. Prophylactic antibiotics in chest trauma: a meta-analysis of high-quality studies. World J Surg . 2006;30(10):1843–1847.
-
- Cicuttin E, Sartelli M, Scozzafava E, Tartaglia D, Cremonini C, Brevi B, et al. Antibiotic prophylaxis in torso, maxillofacial, and skin traumatic lesions: a systematic review of recent evidence. Antibiotics (Basel) . 2022;11(2):139.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
